Company: DVAX
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001029142-25-000049
Chunk: 52

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: 10-K
Item: Item 15
Chunk 52
---
 Station West, LLC10.110-QNovember 6, 2018001-3420710.22•Sublease, dated March 7, 2024, by and between Company and Metagenomi, Inc.10.110-QMay 8, 2024001-34207

115

Table of Contents

10.23•English Translation of Commercial Lease Agreement, dated September 13, 2021, by and between Onyx Düsseldorf S.à r.l. and Dynavax GmbH10.210-QNovember 4, 2021001-3420710.24•English Translation of Addendum to Commercial Lease Agreement, dated January 4, 2024, by and between Onyx Düsseldorf S.à r.l. and Dynavax GmbHX10.25•Lease Agreement, dated March 15, 2022, by and between Company and SPUS8 2100 Powell, L.P.10.110-QMay 5, 2022001-3420710.26•First Amendment to Lease, dated December 2, 2024, by and between Company and SPUS8 2100 Powell, L.P.X10.27†Commercial Manufacturing and Supply Agreement, dated November 22, 2013, between Company and Baxter Pharmaceutical Solutions LLC10.3310-KMarch 8, 2018001-3420710.28^First Amendment to Commercial Manufacturing and Supply Agreement, dated September 10, 2021, by and between Company and Baxter Pharmaceutical Solutions LLC10.310-QNovember 4, 2021001-3420710.29^Second Amendment to Commercial Manufacturing and Supply Agreement, dated as of January 16, 2025, by and between Company and Baxter Pharmaceutical Solutions LLC d/b/a Simtra Biopharma Solutions X10.30^Supply Agreement, dated February 10, 2025, between Company and West Pharmaceutical Services, Inc.X10.31^Agreement, dated January 29, 2021 between Company and Coalition for Epidemic Preparedness Innovations10.3110-KFebruary 25, 2021001-3420710.32^First Amendment to Agreement, dated May 3, 2021, by and between Company and Coalition for Epidemic Preparedness Innovations10.110-QAugust 4, 2021001-34207

116

Table of Contents

10.33^Waiver and Second Amendment to Agreement, dated effective as of April